|
| Cases |
From the Interventional Cardiology Unit (Latib, Ielasi, Montorfano, Colombo), San Raffaele Scientific Institute, and the Interventional Cardiology Unit (Colombo), EMO-GVM Centro Cuore Columbus, Milan, Italy
Correspondence to: Dr. Antonio Colombo, EMO-GVM Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy; fax 39 02 48193433; info{at}emocolumbus.it
A 75-year-old hypertensive woman with a family history of coronary artery disease and infrequent episodes of paroxysmal atrial fibrillation was admitted with a 2-hour history of epigastric pain. An electrocardiogram showed evidence of atrial fibrillation with a rapid ventricular response (138 beats/min) and T-wave inversion inferolaterally (Figure 1A). The cardiac troponin I level was markedly elevated at 10.48 (normal < 0.07 µg/L). The patient was given acetylsalicylic acid, clopidogrel, enoxaparin, amiodarone and irbesartan–hydrochlorothiazide. Pharmacologic cardioversion to sinus rhythm occurred within a few hours.
|
Coronary angiography for a suspected acute coronary syndrome did not show significant coronary artery disease. A left ventriculogram showed severe systolic dysfunction of the apical and middle segments, with preserved contraction of the basal segments (Figures 1B and 1C; video available at www.cmaj.ca/cgi/content/full/180/10/1033/DC1). Conservative treatment was begun, and follow-up echocardiography 2 days later showed improved apical contraction and normal left ventricular function. Based on a history of transient left ventricular dysfunction, electrocardiographic abnormalities and an absence of obstructive coronary artery disease, we diagnosed tako-tsubo cardiomyopathy.
| Discussion |
|---|
|
|
|---|
Its most common clinical presentation includes dyspnea and chest pain mimicking an acute coronary syndrome but without obstructive coronary artery disease. 1,3 Tako-tsubo cardiomyopathy may be associated with cardiac arrhythmias, including sinus bradycardia, atrioventricular block, atrial fibrillation and ventricular tachycardia or fibrillation. 2
Although tako-tsubo cardiomypathy is a recognized differential diagnosis of acute coronary syndromes, the cardiac troponin I levels in our patient were markedly higher than those previously reported (mean troponin I 0.18 µg/L, interquartile range 0.08–0.69 µg/L; normal < 0.06 µg/L). 4 Atrial fibrillation may occur in 6%–7% of cases; whether this is a precipitant or effect of the catecholamine excess and left ventricular dysfunction is not known. 2
| Risk factors |
|---|
|
|
|---|
Although the precise pathogenesis is unknown, the following mechanisms have been suggested: enhanced sympathoneural activity, cathecholamine-mediated multivessel epicardial spasm, coronary microvascular dysfunction, and a possible direct cathecholamine-mediated myocyte injury and myocardial stunning. 4,5
| Prognosis |
|---|
|
|
|---|
Patients with persistent left ventricular dysfunction at discharge should be prescribed a diuretic and an angiotensin-converting enzyme inhibitor or angiotensin-receptor blocker until left ventricular function returns to normal. 5 In addition, because sympathetic activation is presumed to be pivotal in the pathogenesis, long-term therapy with β-blockers that also have
-adrenergic blocking properties (e.g., carvedilol) should be initiated with the aim of preventing recurrences. 5 However, data are lacking to support these recommendations. Finally, repeat echocardiography should be performed before hospital discharge and after 1–3 months in patients with persistent left ventricular dysfunction.
This case highlights the importance of performing left ventriculography in patients who present with electrocardiographic and cardiac biomarker evidence of acute coronary syndrome but who have normal coronary arteries on angiography.
| Footnotes |
|---|
Competing interests: None declared.
The section Cases presents brief case reports that convey clear, practical lessons. Preference is given to common presentations of important rare conditions, and important unusual presentations of common problems. Articles start with a brief summary (100 words) outlining the case and its relevance to a general audience. The case presentation follows (500 words maximum) as well as a discussion of the underlying condition (1000 words maximum). Generally, up to 5 references are permitted and visual elements (e.g., tables of the differential diagnosis, clinical features or diagnostic approach) are encouraged. Written consent from patients for publication of their story is a necessity and should accompany submissions. See information for authors at www.cmaj.ca.
| REFERENCES |
|---|
|
|
|---|
Related Articles
Read all eLetters
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||